FR2748753B1 - Nouveaux vecteurs adenoviraux pour la therapie genique - Google Patents

Nouveaux vecteurs adenoviraux pour la therapie genique

Info

Publication number
FR2748753B1
FR2748753B1 FR9606213A FR9606213A FR2748753B1 FR 2748753 B1 FR2748753 B1 FR 2748753B1 FR 9606213 A FR9606213 A FR 9606213A FR 9606213 A FR9606213 A FR 9606213A FR 2748753 B1 FR2748753 B1 FR 2748753B1
Authority
FR
France
Prior art keywords
gene therapy
adenoviral vectors
new adenoviral
new
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9606213A
Other languages
English (en)
Other versions
FR2748753A1 (fr
Inventor
Monika Lusky
Pierre Leroy
Majid Mehtali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR9606213A priority Critical patent/FR2748753B1/fr
Priority to PCT/FR1997/000882 priority patent/WO1997044475A1/fr
Priority to AU30361/97A priority patent/AU3036197A/en
Publication of FR2748753A1 publication Critical patent/FR2748753A1/fr
Application granted granted Critical
Publication of FR2748753B1 publication Critical patent/FR2748753B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
FR9606213A 1996-05-20 1996-05-20 Nouveaux vecteurs adenoviraux pour la therapie genique Expired - Fee Related FR2748753B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9606213A FR2748753B1 (fr) 1996-05-20 1996-05-20 Nouveaux vecteurs adenoviraux pour la therapie genique
PCT/FR1997/000882 WO1997044475A1 (fr) 1996-05-20 1997-05-20 Vecteurs adenoviraux pour la therapie genique
AU30361/97A AU3036197A (en) 1996-05-20 1997-05-20 Adenovirus vectors for gene therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9606213A FR2748753B1 (fr) 1996-05-20 1996-05-20 Nouveaux vecteurs adenoviraux pour la therapie genique

Publications (2)

Publication Number Publication Date
FR2748753A1 FR2748753A1 (fr) 1997-11-21
FR2748753B1 true FR2748753B1 (fr) 1998-08-14

Family

ID=9492265

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9606213A Expired - Fee Related FR2748753B1 (fr) 1996-05-20 1996-05-20 Nouveaux vecteurs adenoviraux pour la therapie genique

Country Status (3)

Country Link
AU (1) AU3036197A (fr)
FR (1) FR2748753B1 (fr)
WO (1) WO1997044475A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782732A1 (fr) * 1998-08-28 2000-03-03 Transgene Sa Systeme d'expression inductible
DE19856065A1 (de) * 1998-12-04 2000-06-15 Centeon Pharma Gmbh Rekombinanter, adenoviraler Vektor mit limitierter Autoreplikationsfähigkeit in vivo
EP1227837B1 (fr) 1999-10-22 2008-05-21 Aventis Pasteur Limited Procede visant a provoquer et/ou stimuler une reponse immunitaire aux antigenes tumoraux
ES2276788T3 (es) 2000-05-10 2007-07-01 Sanofi Pasteur Limited Polipeptidos inmunogenos codificados por minigenes mage y sus utilizaciones.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003769A1 (fr) * 1991-08-20 1993-03-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTEMENT OF HEALTH AND HUMAN SERVICES Transfert induit par adenovirus de genes vers la voie gastro-intestinale
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation

Also Published As

Publication number Publication date
FR2748753A1 (fr) 1997-11-21
AU3036197A (en) 1997-12-09
WO1997044475A1 (fr) 1997-11-27

Similar Documents

Publication Publication Date Title
DE69637432D1 (de) Adenovirale vektoren für die gentherapie
DZ2254A1 (fr) Analogues d'indazole nouveaux.
DE69738801D1 (de) Verbessertes Selbstbedienungssystem
FR2743265B1 (fr) Chaussure pour la pratique du monoski
DE69737118D1 (de) Doppelschneckenkneter
DE69730617D1 (de) Herzunterstützungssystem
DE69731674D1 (de) Silencieux d'aspiration pour compresseur
NO965304D0 (no) Spillesystem
ITUD940089A0 (it) Scaricatore per bramme sottili
ATE235977T1 (de) Stranggiesskokille
IT1267284B1 (it) Scaricatore per colata continua
GB2322131B (en) Improved retroviral vectors for gene therapy
FR2748753B1 (fr) Nouveaux vecteurs adenoviraux pour la therapie genique
DE59806073D1 (de) Stranggiesseinrichtung
DE69708233T2 (de) Ausguss für das Sranggiessen
FR2737221B1 (fr) Nouveaux vecteurs viraux pour la therapie genique
EP1084236A4 (fr) Nouveaux vecteurs adenoviraux utilises en therapie genique
DE29604595U1 (de) Skistock
DE69700493D1 (de) Telekommunikationssystemarchitektur
DE29709038U1 (de) Selbstschließendes Bodengußsystem
DE29620816U1 (de) Skistock
FR2757265B1 (fr) Revetement pour cible d'archerie
KR970060945U (ko) 주물 시스템
DE29616167U1 (de) Bodenplattensystem
FR2740693B1 (fr) Skis dissymetriques pour neige

Legal Events

Date Code Title Description
ST Notification of lapse